Clinical trial
Prediction of the Response to Chemotherapy by Tomoscintigraphie the MIBI in the Balance Sheet Pre Hodgkin's Disease and Lymphoma Malins High Grade
NCT00551798 is registered in ClinicalTrials.gov with University Hospital, Limoges as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prediction of the Response to Chemotherapy by Tomoscintigraphie the MIBI in the Balance Sheet Pre Hodgkin's Disease and Lymphoma Malins High Grade
- Lead sponsor
- University Hospital, Limoges
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- March 31, 2005
- Completion date
- January 31, 2011
- Enrollment
- 90 (estimated)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.
chemoresistance, hodgkin's disease, malignant lymphomas high grade